(−)-Epicatechin, a Natural Flavonoid Compound, Protects Astrocytes Against Hemoglobin Toxicity via Nrf2 and AP-1 Signaling Pathways
- 18 November 2016
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 54 (10) , 7898-7907
Abstract
(−)-Epicatechin is a brain-permeable, natural product found at high concentrations in green tea and cocoa. Our previous research has shown that (−)-epicatechin treatment reduces hemorrhagic stroke injury via nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathway in vivo. However, the mechanism of action of this compound in modulation of oxidant stress and in protection against hemoglobin-induced astrocyte injury is unclear. Therefore, we explored the cellular and molecular mechanisms that underlie these protective effects in vitro. Mouse primary astrocytes isolated from wild-type mice and Nrf2 knockout (KO) mice were preconditioned with hemoglobin to simulate intracerebral hemorrhage (ICH) in vitro. Effects of (−)-epicatechin were measured by Western blotting, immunostaining, MTT assay, and reactive oxidant stress (ROS) assay. (−)-Epicatechin increased Nrf2 nuclear accumulation and cytoplasmic levels of superoxide dismutase 1 (SOD1) in wild-type astrocytes but did not increase SOD1 expression in Nrf2 knockout (KO) astrocytes. Furthermore, (−)-epicatechin treatment did not alter heme oxygenase 1 (HO1) expression in wild-type astrocytes after hemoglobin exposure, but it did decrease HO1 expression in similarly treated Nrf2 KO astrocytes. In both wild-type and Nrf2 KO astrocytes, (−)-epicatechin suppressed phosphorylated JNK and nuclear expression of JNK, c-jun, and c-fos, indicating that inhibition of activator protein-1 (AP-1) activity by (−)-epicatechin is Nrf2-independent. These novel findings indicate that (−)-epicatechin protects astrocytes against hemoglobin toxicity through upregulation of Nrf2 and inhibition of AP-1 activity. These cellular and molecular effects may partially explain the cerebroprotection as we previously observed for (−)-epicatechin in animal models of ICH.Keywords
Funding Information
- National Institutes of Health (R01NS078026, R01AT007317)
- American Heart Association (13GRNT15730001)
This publication has 61 references indexed in Scilit:
- Cerebroprotection by the neuronal PGE2 receptor EP2 after intracerebral hemorrhage in middle-aged miceJournal of Cerebral Blood Flow & Metabolism, 2016
- Cerebroprotection of flavanol (-)-epicatechin after traumatic brain injury via Nrf2-dependent and -independent pathwaysFree Radical Biology and Medicine, 2016
- Microglial Polarization and Inflammatory Mediators After Intracerebral HemorrhageMolecular Neurobiology, 2016
- Inflammation in intracerebral hemorrhage: From mechanisms to clinical translationProgress in Neurobiology, 2014
- Pharmacokinetics and Blood–Brain Barrier Penetration of (+)-Catechin and (−)-Epicatechin in Rats by Microdialysis Sampling Coupled to High-Performance Liquid Chromatography with Chemiluminescence DetectionJournal of Agricultural and Food Chemistry, 2012
- Adenosine‐5′‐Triphosphate‐Adenosine‐Glutathione Cross‐Linked Hemoglobin as Erythropoiesis‐Stimulating AgentArtificial Organs, 2012
- Insights into the putative catechin and epicatechin transport across blood-brain barrierFood & Function, 2010
- Alternate Pathways Preserve Tumor Necrosis Factor-α Production After Nuclear Factor-κB Inhibition in Neonatal Cerebral Hypoxia–IschemiaStroke, 2009
- Transcription Factor Nrf2 Protects the Brain From Damage Produced by Intracerebral HemorrhageStroke, 2007
- Tin-mesoporphyrin, a potent heme oxygenase inhibitor, for treatment of intracerebral hemorrhage: in vivo and in vitro studies.2000